4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0002065269-26-000002
Options or other derivatives
- Chief Medical Officer acquired 441,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hall Jesse Wayne · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 1 in the form Restricted Stock Units | +98,100 | 98,100 | D |
| 2026-02-02 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +343,300 | 343,300 | D |
Loading xslF345X05/form4-02062026_110246.xml…